c reactive protein crp (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
c reactive protein crp
C Reactive Protein Crp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p1823/C-Reactive+Protein/pm42139097-71-16-33
Average 94 stars, based on 3 article reviews
C Reactive Protein Crp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p1823/C-Reactive+Protein/pm42139097-71-16-33
Average 94 stars, based on 3 article reviews
c reactive protein crp - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: C-reactive protein and cardiovascular diseases: a synthesis of studies based on different designs. Article Snippet: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Table 1 A summary of studies on the relationship between CRP and CVDs Author, year Methods to estimate associations Subjects or study populations Sample size (cases/all) Main findings Animal experiments Paul, 200417 Compared atherosclerotic lesions between huCRPtg+/ApoE−/− and huCRPtg−/ApoE−/− Mice 209 CRP↑ CVD↑ Kovacs, 200718 Compared atherosclerotic lesions between huCRPtg+/LDLR−/− and huCRPtg−/LDLR−/− Mice 105 CRP↑ CVD↓ Koike, 200919 Compared the susceptibility to cholesterol-rich diet-induced aortic and coronary atherosclerosis between huCRPtg+ and huCRPtg− Rabbits 26 Null association Traditional observational studies Rutter, 200420 Compared the 7-y incidence of CVD events between the highest and lowest CRP quartile Framingham Offspring Study in the USA 189/3037 CRP↑ CVD↑ Cushman, 200521 Compared the 10-y incidence of CHD between CRP >3 mg/L and CRP <1 mg/L Cardiovascular Health Study in the USA 547/3971 CRP↑ CVD↑ Chen, 202222 Compared the 4.62-y incidence of CVD among quartiles of 7-y cumulative burden of CRP Kailuan study in China 2118/34 959 CRP↑ CVD↑ Mendelian randomization studies Elliott, 200923 MR between CRP and CHD Multiple European studies 28 112/128 935 Null association Wensley, 201124 MR between CRP and CHD Multiple European studies 46 557/194 418 Null association Wang, 202225 MR between CRP and CHD Multiple European and East Asian studies 121 072/494 478 Null association Clinical trials Ridker, 200826 Compared the 1.9-y incidence of MCE between Rosuvastatin group and Placebo group JUPITER 393/17 802 CRP↓ CVD↓ Ridker, 201727 Compared the Article Title: The intensity of exercise and inflammation markers in women with overweight & obesity: a systematic review and network meta-analysis. Article Snippet: OBJECTIVES: The purpose of this network meta-analysis (NMA) of randomized controlled trials (RCT) was to examine the effects of different exercise intensities on inflammatory markers in women with overweight/obesity.. METHODS: A systematic search for RCTs that met the inclusion criteria for the period up to October 2024. random effects NMA was performed within a frequency-based framework.. RESULTS: A total of 75 RCTs were included (3989 participants). Article Title: 2025 ICM: Debridement, Antibiotics, and Implant Retention (DAIR). Article Snippet: James Cashman, MD, Seyed Mohammad Javad Mortazavi, MD, Pier Francesco Indelli, Siddharth Rele, MD PhD, Carl Haasper, Fatih YILDIZ, MD, Christopher T. Holland, MD MS, Juan D. Lizcano, MD, Álvaro Auñón-Rubio, MD, PhD, Don Bambino Geno Tai, Bartolome Allende, Abtin Alvand, Claudia Arias, Armin Arshi, MD, Vasily Artyukh, MD, George C. Babis, MD, Jose Baeza-Oliete, Nicolaas Budhiparama, Frank Buttacavoli, MD, Pedro Ivo Carvalho, Felix C. Vilchez Cavazos, Cheng-Fong Chen, MD, Pawel Chodór, Peter F.M.. Choong, MD, Osman ÇILOGLU, MD, David Dewar, Fundación Jiménez Díaz, Goksel Dikmen, MD Msc, Ayman Ebied, Sina Esmaeili, MD, Jonathan T. Evans, BMedSci, BMBS, MSc, MD, FRCS (Tr & Orth), Guilherme Falotico, MD MSc PhD, Peter Gold, MD, Enrique Gómez-Barrena, MD, Joan GómezJunyent, MD, MSc, PhD, Daniel Gould, MD PhD, Akram A. HAMMAD, MD, HyukSoo Han, MD, PhD, Christian Hipfl, MD, Catriona Hunter, MRCS, Mustafa Alper INCESOY, MD, Nathan B. Kaplan, Kayahan Karaytug, MD, Huiwu LI, MD, Francisco Arguelles Linares, MD, Jorge Manrique-Succar, MD, Oliver Marín-Peña, MD, Paul McCarroll, Robert McCulloch, MBChB MSc FRCS(Tr&Orth), Rene Mihalič, Laura Morata, Seyed Amirsadegh Mortazavi, Sumon Nandi, MD MBA, Elise Naufal, BA, Julio César Palacios, MD, Juan Carlos Martinez Pastor, MD, PhD, Tim Petheram, MBChB MSc FRCS (Tr & Orth), Alaina Ritter, Ola Rolfson, PhD, Javier Martinez Ros, MD PhD, Marisa Sanchez, Ignacio Sancho, Jay D. Shah, Puyi Sheng, Alex Soriano, Mark J. SPANGEHL, MD, Jeffery B. Stambough, MD, Saad Tarabichi, MD, Daniel Taupin, Satit Thiengwittayaporn, I.Remzi Tözün, Rihard Trebše, Shang-Wen Tsai, MD, Ibrahim Tuncay, Ewout S. Veltman, Felix VILCHEZ-CAVAZOS, MD, Marianne Westberg, MD, PhD, Haobo Wu, Piers J. Yates, MBBS, Mehmet Kursat Yilmaz, JeHyun Yoo, MD Imaging:Article Title: Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI. Article Snippet: .. ACEi: Angiotensin-converting enzyme inhibitor; AFL/Afib: Atrial flutter/fibrillation; ARB: Angiotensin II receptor blocker; BMI: Body mass index; BNP: B-type natriuretic peptide; CKD: Chronic kidney disease; Control:Article Title: Effect of luteolin on oxidative stress and inflammation in the human osteoblast cell line hFOB1.19 in an inflammatory microenvironment. Article Snippet: .. The inflammatory Incubation:Article Title: Temporal and spatial effects on C‐reactive protein's regulation of inducible nitric oxide synthase production in periodontal disease Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82001081, 31971282, 82170968; China Postdoctoral Science Foundation, Grant/Award Number: 2020M683266; Chongqing Postdoctoral Science Foundation, Grant/Award Number: csts2020jcyj-bshX0022; 2019 Chongqing Graduate Tutor Team Construction Project, Grant/Award Number: dstd201903; Post-doctoral Innovative Talent Support Program of Chongqing, Grant/Award Number: 2010010006080066 Abstract Background: Inducible nitric oxide synthase (iNOS) is associated with inflammation and osteoclastic differentiation in periodontal disease.. This study was conducted to compare the time-dependent variation in iNOS production between the gingiva and other periodontal tissues and to explore the potential association with C-reactive protein (CRP) in early periodontal disease.. Methods: Ligature-induced periodontal disease models (0–14 days) were established in wild-type and CRP knockout rats. Recombinant:Article Title: Temporal and spatial effects on C‐reactive protein's regulation of inducible nitric oxide synthase production in periodontal disease Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82001081, 31971282, 82170968; China Postdoctoral Science Foundation, Grant/Award Number: 2020M683266; Chongqing Postdoctoral Science Foundation, Grant/Award Number: csts2020jcyj-bshX0022; 2019 Chongqing Graduate Tutor Team Construction Project, Grant/Award Number: dstd201903; Post-doctoral Innovative Talent Support Program of Chongqing, Grant/Award Number: 2010010006080066 Abstract Background: Inducible nitric oxide synthase (iNOS) is associated with inflammation and osteoclastic differentiation in periodontal disease.. This study was conducted to compare the time-dependent variation in iNOS production between the gingiva and other periodontal tissues and to explore the potential association with C-reactive protein (CRP) in early periodontal disease.. Methods: Ligature-induced periodontal disease models (0–14 days) were established in wild-type and CRP knockout rats. |